JG
AZN icon

Jefferies Group’s AstraZeneca AZN Stock Holding History

Jefferies Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,500
Closed -$2.62M – 1535
2021
Q4 		$2.62M Sell
22,500
-37,600
-63% -$4.42M 0.02% 698
2021
Q3 		$7.22M Buy
60,100
+100
+0.2% +$11.6K 0.05% 342
2021
Q2 		$7.19M Sell
60,000
-8,150
-12% -$894K 0.05% 357
2021
Q1 		$6.78M Buy
+68,150
New +$6.85M 0.06% 284
2018
Q3 		– Sell
-40,950
Closed -$2.88M – 2389
2018
Q2 		$2.88M Buy
40,950
+3,900
+11% +$281K 0.02% 713
2018
Q1 		$2.59M Buy
37,050
+25,050
+209% +$1.74M 0.01% 736
2017
Q4 		$833K Buy
+12,000
New +$809K ﹤0.01% 1477
2017
Q3 		– Sell
-131,700
Closed -$8.98M – 2322
2017
Q2 		$8.98M Buy
131,700
+115,800
+728% +$7.56M 0.06% 304
2017
Q1 		$990K Buy
15,900
+2,250
+16% +$131K 0.01% 1280
2016
Q4 		$746K Sell
13,650
-17,250
-56% -$979K ﹤0.01% 1424
2016
Q3 		$2.03M Buy
+30,900
New +$2.02M 0.01% 936
2016
Q1 		– Sell
-47,650
Closed -$3.23M – 2201
2015
Q4 		$3.23M Sell
47,650
-50,200
-51% -$3.29M 0.02% 653
2015
Q3 		$6.23M Sell
97,850
-10,250
-9% -$674K 0.04% 405
2015
Q2 		$6.89M Buy
+108,100
New +$7.4M 0.04% 400
2015
Q1 		– Sell
-1,143,000
Closed -$80.4M – 2075
2014
Q4 		$80.4M Buy
1,143,000
+406,800
+55% +$29.1M 0.47% 38
2014
Q3 		$52.6M Buy
736,200
+53,800
+8% +$3.94M 0.36% 41
2014
Q2 		$50.7M Buy
+682,400
New +$49.3M 0.43% 46
2014
Q1 		– Sell
-90,000
Closed -$5.34M – 2021
2013
Q4 		$5.34M Sell
90,000
-116,900
-57% -$6.35M 0.03% 299
2013
Q3 		$10.7M Buy
206,900
+186,100
+895% +$9.35M 0.11% 166
2013
Q2 		$984K Buy
+20,800
New +$1.06M 0.01% 789

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Jefferies Group's AZN Position: Q3 2022 in Review

Jefferies Group reduced its AstraZeneca (AZN) stake by 18% in Q3 2022, selling an estimated $539K and leaving 19,171 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #587.

Jefferies Group first reported a position in AZN in Q2 2013 and has held it in 33 quarters since. The position peaked at $18.7M in Q2 2014. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Jefferies Group held 19,171 shares of AstraZeneca worth $2.1M as of Q3 2022.
  • Jefferies Group sold 4,252 AstraZeneca shares in Q3 2022, an estimated $539K.
  • AstraZeneca made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #587 holding.
  • Jefferies Group first reported a position in AstraZeneca in Q2 2013 and has held it in 33 quarters since.
  • Jefferies Group's AstraZeneca position peaked at $18.7M in Q2 2014.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.